# Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness

> **NCT02167620** · PHASE4 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 35 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Schizophrenia

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02167620
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2018-02
- **Final completion:** 2018-03
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02167620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02167620, "Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02167620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*